The Quorum Health Corporation (NYSE:QHC) is going down by -34.55% in today’s trading session, a fall equivalent to -0.38% of the stock’s price from yesterday’s market close. A news came out 19 hours ago stating that Quorum Health Corporation Announces Third Quarter 2019 Results by WSJ. The lowest point that the shares touched during the trading session was $1.10, while the peak of the day was recorded at a share price of $1.17. QHC finished the previous session at $1.10 according to the data provided by Barchart, while the trading volume was observed to be $1444084.

In the 100 days of trading, QHC managed to top a 1.31% Moving average. Additionally, Quorum Health Corporation shares have achieved a 52-week range between 0.91 and 5.74 alongside 100 days raw stochastic set at 4.13%.

The number of shares outstanding, according to the fundamentals of the company, is set at 30.93M, equal to the value of $34.02M in market capitalization. In the last 30 days, Quorum Health Corporation shares went down by -47.41%, adding 1.35 to growth in value, on top of a +7.58% boost since 10/08/19.

Quorum Health Corporation (NYSE:QHC) Analyst’s Estimates

Quorum Health Corporation (QHC) could record at least -$0.17 per share in quarterly earnings in the upcoming report on 03/12/2020, a number that would actually represent a decrease of -0.63 YOY.

According to the average analyst rating, Quorum Health Corporation would be rated as Hold. Out of 1 different analysts monitoring QHC stock, 0 analysts rate the stock as a BUY, 1 suggest to give the rating of HOLD, 0 indicate that QHC is an OVERWEIGHT, 0 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERWEIGHT.

On December 20, 2017, the stock earned a Upgrade rating due to a new analyst call from Morgan Stanley, while analysts from Morgan Stanley believe that the stock is set at Underweight, as concluded on June 07, 2017. Deutsche Bank, is still rather wary about the stock, deciding to keep the rating at Hold as confirmed through a call on April 05, 2017.

QHC Key Ratios To Watch:

Taking in account the profitability of the Company, gross profit margin of +2.39% has been attained, while the operating margin has been recorded at +2.39%. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at -11.77%. Beta value of the stock is recorded at 2.01. Additionally, Quorum Health Corporation is recording price volatility of 8.01% for the period of the last seven days and 6.70% in the last 30 days.

Quorum Health Corporation (NYSE:QHC) Technical Outlook

For the period of the last 50 days, Quorum Health Corporation had its Raw Stochastic average set at 5.26% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 7.46%. Stochastic %K for Quorum Health Corporation, with the last 20 days included, was set at 20.32%, having Stochastic %D topping 27.55%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be discouraging for Quorum Health Corporation stocks with recording -61.94% in metrics.

Quorum Health Corporation Insider Watch:

Similarly, 107.91% of the company’s float is held by institutions – and there are 148 institutions in total holding shares of this company. The top three institutional holders of QHC stocks are: Kohlberg Kravis Roberts & Co. L.P. with ownership of $4.0 million, which is approximately 2988781 of the company’s shares; York Capital Management Global Advisors, LLC, holding 2980000 shares of the stock with an approximate value of $4.0 million; and Davidson Kempner Capital Management LP, currently with more than 2971526 shares of the company valued at $4.0 million. Positions in Quorum Health Corporation stocks held by institutional investors has been changing actively in the past six months, a period during which there were 15 insider purchases amounting to 1112407 shares.